📰 Expanded Access Protocol News
Page 5 - Expanded Access Protocol News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Expanded Access Protocol. Real-time updates on events, politics, business and more.
December 21, 2020
GENEVA, SWITZERLAND / ACCESSWIRE / December 21, 2020 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) (" Relief" or the " Company"), a biopharmaceutical company with its lead compound RLF-100 TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today announced the appointment of Christiaan ("Chris") L.J.J. Stijnen as Chief Commercial Officer (CCO) effective December 21, 2020. Mr. Stijnen will strengthen the management team in all activities pertaining to the...
December 18, 2020
GENEVA, SWITZERLAND / ACCESSWIRE / December 18, 2020 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) (" Relief" or the " Company"), a biopharmaceutical company with its lead compound RLF-100 TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, announces that all agenda items of yesterdays Extraordinary General Meeting (" EGM") were approved with a large majority (more than 90 percent) of the represented votes. As a result of the exceptional circumstances du...
December 18, 2020
RELIEF THERAPEUTICS Holdings A EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): AGMEGM Relief Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG Approved with Large Majority 18.12.2020 / 07:00 RELIEF THERAPEUTICS Holding AG Approved with Large Majority Geneva, Switzerland, December 18, 2020 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (" Relief" or the " Company"), a biopharmaceutical company with its lead compound RLF-100 TM (avipt...
December 18, 2020
12/18/2020 | Press release | Distributed by Public on 12/18/2020 00:05 Relief Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG Approved with Large Majority Geneva, Switzerland, December 18, 2020 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (Relief or the Company), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, announces that all agenda items of yesterday...